Amlodipine Besylate
Product Images NDC 68151-0995

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68151-0995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8352ab43-figure-01 (8352ab43 Figure 01)

Chemical structure of Amlodipine Besylate, showing its molecular framework including aromatic rings, functional groups, and side chains.*

FDA Label Image

8352ab43-figure-02 (8352ab43 Figure 02)

A Kaplan-Meier curve showing event rates over 24 months comparing Amlodipine and Placebo. The x-axis represents time in months, and the y-axis shows event rates. The graph includes a p-value of 0.003 and a hazard ratio of 0.691 with 95% confidence interval from 0.54 to 0.88, indicating statistical comparison between the two groups.*

FDA Label Image

8352ab43-figure-03 (8352ab43 Figure 03)

A forest plot chart showing hazard ratios with 95% confidence intervals comparing the effects of Amlodipine versus placebo across various patient subgroups, including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI-stent strata.*

FDA Label Image

Label Image (Lbl681510995)

Label for Amlodipine Besylate 10 mg tablet. The label includes manufacturing information by Invagen, lot number, expiration date 07/14, and a barcode. It indicates prescription use only and shows the product NDC 68151-0995 associated with Carilion Materials Management.*

FDA Label Image

Table1 (Tab1)

A data table comparing the incidence of side effects including edema, dizziness, flushing, and palpitation among groups receiving Amlodipine at doses of 2.5 mg, 5 mg, and 10 mg, versus a placebo group. The table shows the number of subjects in each dose group and placebo group along with the corresponding incidence percentages for each side effect.*

FDA Label Image

Table2 (Tab2)

A tabular data presentation comparing the percentages of reported side effects—fatigue, nausea, abdominal pain, and somnolence—between patients taking Amlodipine Besylate tablets (N=1730) and those on placebo (N=1250). Fatigue and nausea are reported more frequently with Amlodipine Besylate than placebo.*

FDA Label Image

Table3 (Tab3)

A data table showing the percentages of adverse effects in male and female subjects treated with Amlodipine besylate tablets versus placebo. The effects listed are edema, flushing, palpitations, and somnolence, with separate data for males and females in each group, including sample sizes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.